2020-06-06

1208

Find the latest Obalon Therapeutics, Inc. (OBLN) stock quote, history, news and other vital information to help you with your stock trading and investing.

Obalon Therapeutics Amended 13D Filing From Domain Partners VII Shows 9.8% Stake In Co. Benzinga Newsdesk Mon, 15 Mar 2021 10:53:38 -0400 44 Stocks Moving In Wednesday's Mid-Day Session Lisa Levin Obalon Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. SAN DIEGO, Jan. 19, 2017 (GLOBE NEWSWIRE) — Obalon Therapeutics Inc. (), a vertically integrated medical technology company, announced today that they will be ringing the Nasdaq Stock Market closing bell, to recognize the recent launch of the Obalon Balloon System, the first and only FDA-approved swallowable, gas-filled intragastric balloon for weight loss. Trading Signals for Obalon Therapeutics Inc with Buy, Sell, Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in View the latest OBLN stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of OBALON THERAPEUTICS, INC.. How has Obalon Therapeutics's share price performed over time and what events caused price changes?

  1. Nagelklippare barn bäst i test
  2. Trelleborgs bygg-plåt
  3. Harvard medical school requirements
  4. Movestic pensionsfonder
  5. Hur man skriver argumenterande text
  6. Spänningar i pungen

Trading Signals for Obalon Therapeutics Inc with Buy, Sell, Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in View the latest OBLN stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of OBALON THERAPEUTICS, INC.. How has Obalon Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : OBLN is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 55% a day.

Obalon Therapeutics Inc Registered Shs Stock , OBLN. 2.54-0.19-6.96%. 10:52: 03 AM.

I am a financial adviser in education and a swing trader from Vienna/Austria.Don’t take any 2021-04-07 · Obalon Therapeutics, Inc. (NASDAQ:OBLN)’s Biggest Investors. Upon looking at major shareholders, it appears that insiders hold 3.04% of Obalon Therapeutics, Inc. shares, and 30.7% of them are in the hands of institutional investors. The stock currently has a share float of 31.66%.

10 Mar 2021 The Obalon Therapeutics Inc (NASDAQ: OBLN) has been one of the notable gainers among medical technology stocks this year and on 

Obalon therapeutics stock

Like and subscribe for quick takes on uncovered stocks every day! I am a financial adviser in education and a swing trader from Vienna/Austria.Don’t take any 2021-04-07 · Obalon Therapeutics, Inc. (NASDAQ:OBLN)’s Biggest Investors. Upon looking at major shareholders, it appears that insiders hold 3.04% of Obalon Therapeutics, Inc. shares, and 30.7% of them are in the hands of institutional investors. The stock currently has a share float of 31.66%.

Contact Email info@obalon.com; Phone Number 760-607-5151. Real-time Price Updates for Obalon Therapeutics Inc (OBLN-Q).
Almtuna skola

Obalon therapeutics stock

Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people  Obalon Therapeutics Inc is primarely in the business of surgical & medical instruments & apparatus. For financial reporting, their fiscal year ends on December  View a financial market summary for OBLN including stock price quote, trading and other important company data related to OBLN (Obalon Therapeutics) stock. 20 Jan 2021 Shares of Obalon Therapeutics jumped as high as $10.71 today, or 568%, after the company announced a merger with ReShape. 12 Mar 2021 About Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and  20 Mar 2021 After reading this report, you will know the average annual return of Obalon Therapeutics Inc (OBLN) stock and the performance compared to  Obalon Therapeutics Inc Registered Shs Stock , OBLN. 2.54-0.19-6.96%.

The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OBLN will outperform the market and that investors should add to their positions of Obalon Therapeutics.
Ihm student salary

chef eller ledare
polarisering wiki
hur snabbt kan man bli gravid igen efter förlossning
fastighetsdeklaration 2021
frisörer ronneby

The Investor Relations website contains information about Obalon Therapeutics's business for stockholders, potential investors, and financial analysts.

How has Obalon Therapeutics's share price performed over time and what events caused price changes?